David A. Gonyer, President and CEO at Evoke Pharma Inc (EVOK), sold 144,000 shares at $2.94 ($420K) on 2020-12-14, disclosed to the SEC on 2020-12-14.
Open-market sale of $420k EVOK by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.90 | 48,046 | $139K | 33.2% |
| 2 | $2.90 | 48,046 | $139K | 33.2% |
| 3 | $2.94 | 23,954 | $70K | 16.8% |
| 4 | $2.94 | 23,954 | $70K | 16.8% |
| Total | $2.91 avg | 144,000 | $420K | 100% |